{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T16:57:19Z","timestamp":1790787439720,"version":"4.1.0"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,8,21]],"date-time":"2020-08-21T00:00:00Z","timestamp":1597968000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004097","name":"Fondation ARC pour la Recherche sur le Cancer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004097","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002915","name":"Fondation pour la Recherche M\u00e9dicale","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002915","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy - Oncolytics"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.omto.2020.08.011","type":"journal-article","created":{"date-parts":[[2020,8,25]],"date-time":"2020-08-25T16:21:05Z","timestamp":1598372465000},"page":"573-578","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["High Oncolytic Activity of a Double-Deleted Vaccinia Virus Copenhagen Strain against Malignant Pleural Mesothelioma"],"prefix":"10.1016","volume":"18","author":[{"given":"Tiphaine","family":"Delaunay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joelle","family":"Nader","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion","family":"Grard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Farine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vera","family":"Hedwig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johann","family":"Foloppe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thibaut","family":"Blondy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathilde","family":"Violland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Pouliquen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Gr\u00e9goire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Boisgerault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Erbs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Fran\u00e7ois","family":"Fonteneau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omto.2020.08.011_bib1","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1038\/nrc.2017.42","article-title":"Novel insights into mesothelioma biology and implications for therapy","volume":"17","author":"Yap","year":"2017","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.omto.2020.08.011_bib2","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.omto.2017.08.004","article-title":"Infectious Optimism following the 10th International Oncolytic Virus Meeting","volume":"7","author":"Atherton","year":"2017","journal-title":"Mol. Ther. Oncolytics"},{"key":"10.1016\/j.omto.2020.08.011_bib3","doi-asserted-by":"crossref","first-page":"96","DOI":"10.3389\/fonc.2017.00096","article-title":"Genetically Engineered Vaccinia Viruses As Agents for Cancer Treatment, Imaging, and Transgene Delivery","volume":"7","author":"Haddad","year":"2017","journal-title":"Front. Oncol."},{"key":"10.1016\/j.omto.2020.08.011_bib4","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1097\/00002371-199805000-00007","article-title":"Cytokine gene therapy or infusion as treatment for solid human cancer","volume":"21","author":"Robinson","year":"1998","journal-title":"J.\u00a0Immunother."},{"key":"10.1016\/j.omto.2020.08.011_bib5","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/sj.cgt.7700133","article-title":"Replication-restricted vaccinia as a cytokine gene therapy vector in cancer: persistent transgene expression despite antibody generation","volume":"7","author":"Mukherjee","year":"2000","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.omto.2020.08.011_bib6","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1089\/hum.2008.036","article-title":"Novel oncolytic agent GLV-1h68 is effective against malignant pleural mesothelioma","volume":"19","author":"Kelly","year":"2008","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omto.2020.08.011_bib7","doi-asserted-by":"crossref","first-page":"3791","DOI":"10.1158\/1078-0432.CCR-08-3236","article-title":"Imaging a Genetically Engineered Oncolytic Vaccinia Virus (GLV-1h99) Using a Human Norepinephrine Transporter Reporter Gene","volume":"15","author":"Brader","year":"2009","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.omto.2020.08.011_bib8","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.surg.2013.06.004","article-title":"An oncolytic vaccinia virus expressing the human sodium iodine symporter prolongs survival and facilitates SPECT\/CT imaging in an orthotopic model of malignant pleural mesothelioma","volume":"154","author":"Belin","year":"2013","journal-title":"Surgery"},{"key":"10.1016\/j.omto.2020.08.011_bib9","doi-asserted-by":"crossref","first-page":"4388","DOI":"10.1158\/1078-0432.CCR-18-0244","article-title":"Phase I Study of Oncolytic Vaccinia Virus GL-ONC1 in Patients with Peritoneal Carcinomatosis","volume":"24","author":"Lauer","year":"2018","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.omto.2020.08.011_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.omto.2019.03.005","article-title":"The Enhanced Tumor Specificity of TG6002, an Armed Oncolytic Vaccinia Virus Deleted in Two Genes Involved in Nucleotide Metabolism","volume":"14","author":"Foloppe","year":"2019","journal-title":"Mol. Ther. Oncolytics"},{"key":"10.1016\/j.omto.2020.08.011_bib11","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1038\/onc.2014.155","article-title":"Ribonucleotide reductase and cancer: biological mechanisms and targeted therapies","volume":"34","author":"Aye","year":"2015","journal-title":"Oncogene"},{"key":"10.1016\/j.omto.2020.08.011_bib12","doi-asserted-by":"crossref","first-page":"44892","DOI":"10.18632\/oncotarget.6285","article-title":"Sensitivity of pleural mesothelioma to oncolytic measles virus depends on defects of the type I interferon response","volume":"6","author":"Achard","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.omto.2020.08.011_bib13","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1128\/JVI.01617-08","article-title":"Vaccinia virus-mediated inhibition of type I interferon responses is a multifactorial process involving the soluble type I interferon receptor B18 and intracellular components","volume":"83","author":"Waibler","year":"2009","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.omto.2020.08.011_bib14","doi-asserted-by":"crossref","first-page":"e1091554","DOI":"10.1080\/2162402X.2015.1091554","article-title":"CXCL11-Armed oncolytic poxvirus elicits potent antitumor immunity and shows enhanced therapeutic efficacy","volume":"5","author":"Liu","year":"2015","journal-title":"OncoImmunology"},{"key":"10.1016\/j.omto.2020.08.011_bib15","doi-asserted-by":"crossref","first-page":"e1395997","DOI":"10.1080\/2162402X.2017.1395997","article-title":"Intra-tumoral delivery of CXCL11 via a vaccinia virus, but not by modified T\u00a0cells, enhances the efficacy of adoptive T\u00a0cell therapy and vaccines","volume":"7","author":"Moon","year":"2018","journal-title":"OncoImmunology"},{"key":"10.1016\/j.omto.2020.08.011_bib16","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1245\/s10434-014-3651-4","article-title":"Oncolytic vaccinia virus as an adjuvant treatment to cytoreductive surgery for malignant peritoneal mesothelioma","volume":"21","author":"Acuna","year":"2014","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.omto.2020.08.011_bib17","doi-asserted-by":"crossref","first-page":"4146","DOI":"10.1158\/0008-5472.CAN-16-2165","article-title":"Immune Checkpoint Blockade, Immunogenic Chemotherapy or IFN-\u03b1 Blockade Boost the Local and Abscopal Effects of Oncolytic Virotherapy","volume":"77","author":"Fend","year":"2017","journal-title":"Cancer Res."},{"key":"10.1016\/j.omto.2020.08.011_bib18","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.2147\/OTT.S126320","article-title":"Immunogenicity of oncolytic vaccinia viruses JX-GFP and TG6002 in a human melanoma in\u00a0vitro model: studying immunogenic cell death, dendritic cell maturation and interaction with cytotoxic T lymphocytes","volume":"10","author":"Heinrich","year":"2017","journal-title":"OncoTargets Ther."},{"key":"10.1016\/j.omto.2020.08.011_bib19","doi-asserted-by":"crossref","first-page":"e1407897","DOI":"10.1080\/2162402X.2017.1407897","article-title":"Oncolytic viruses sensitize tumor cells for NY-ESO-1 tumor antigen recognition by CD4+ effector T\u00a0cells","volume":"7","author":"Delaunay","year":"2017","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.omto.2020.08.011_bib20","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/sj.cgt.7701098","article-title":"Modified vaccinia virus Ankara as a vector for suicide gene therapy","volume":"15","author":"Erbs","year":"2008","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.omto.2020.08.011_bib21","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/j.ajpath.2010.12.014","article-title":"Identification of novel markers for the diagnosis of malignant pleural mesothelioma","volume":"178","author":"Gueugnon","year":"2011","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.omto.2020.08.011_bib22","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1038\/gt.2008.82","article-title":"Targeted delivery of a suicide gene to human colorectal tumors by a conditionally replicating vaccinia virus","volume":"15","author":"Foloppe","year":"2008","journal-title":"Gene Ther."},{"key":"10.1016\/j.omto.2020.08.011_bib23","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/nmeth.2019","article-title":"Fiji: an open-source platform for biological-image analysis","volume":"9","author":"Schindelin","year":"2012","journal-title":"Nat. Methods"}],"container-title":["Molecular Therapy - Oncolytics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2372770520301285?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2372770520301285?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,13]],"date-time":"2024-12-13T23:01:15Z","timestamp":1734130875000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2372770520301285"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":23,"alternative-id":["S2372770520301285"],"URL":"https:\/\/doi.org\/10.1016\/j.omto.2020.08.011","relation":{},"ISSN":["2372-7705"],"issn-type":[{"value":"2372-7705","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"High Oncolytic Activity of a Double-Deleted Vaccinia Virus Copenhagen Strain against Malignant Pleural Mesothelioma","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy - Oncolytics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omto.2020.08.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors.","name":"copyright","label":"Copyright"}]}}